About this trial

This registry has been established to gain a better understanding of the clinical and biological characteristics and outcome of patients with lymphoid cancer

Eligibility criteria

Qualifiers

Male or female patients 18 years or older

Written informed consent

Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Patient registry

Treatment groups

6,000 Participants
are divided into 3 treatment groups

Locations

1
Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII24127, Bergamo Italy

Sponsors and collaborators

A.O. Ospedale Papa Giovanni XXIII

Lead sponsor